COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations. La presente invención se r...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | STACEY A. VOSS SUSAN E. CHANIEWSKI MIN GAO AMY K. SHEAFFER FIONA MCPHEE JULIE A. LEMM |
| description | The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.
La presente invención se refiere en general a compuestos antivirales, y más específicamente se dirige a combinaciones de compuestos los cuales pueden inhibir el virus de la Hepatitis C (HCV), composiciones que comprenden tales compuestos, y métodos para tratar la Hepatitis C usando tales combinaciones. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX351910B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX351910B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX351910B3</originalsourceid><addsrcrecordid>eNrjZPB39vd18vRzDPH09wtW8HdTcFQIDnB19nTzdFbwcA5T8As2dVTw9PPwdPIM8Q9ScPRzAWKojLFCQJB_iKtjsCtCBQ8Da1piTnEqL5TmZpBzcw1x9tBNLciPTy0uSExOzUstifeNMDY1tDQ0cDImqAAA56ktBA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR</title><source>esp@cenet</source><creator>STACEY A. VOSS ; SUSAN E. CHANIEWSKI ; MIN GAO ; AMY K. SHEAFFER ; FIONA MCPHEE ; JULIE A. LEMM</creator><creatorcontrib>STACEY A. VOSS ; SUSAN E. CHANIEWSKI ; MIN GAO ; AMY K. SHEAFFER ; FIONA MCPHEE ; JULIE A. LEMM</creatorcontrib><description>The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.
La presente invención se refiere en general a compuestos antivirales, y más específicamente se dirige a combinaciones de compuestos los cuales pueden inhibir el virus de la Hepatitis C (HCV), composiciones que comprenden tales compuestos, y métodos para tratar la Hepatitis C usando tales combinaciones.</description><language>eng ; spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171103&DB=EPODOC&CC=MX&NR=351910B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171103&DB=EPODOC&CC=MX&NR=351910B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>STACEY A. VOSS</creatorcontrib><creatorcontrib>SUSAN E. CHANIEWSKI</creatorcontrib><creatorcontrib>MIN GAO</creatorcontrib><creatorcontrib>AMY K. SHEAFFER</creatorcontrib><creatorcontrib>FIONA MCPHEE</creatorcontrib><creatorcontrib>JULIE A. LEMM</creatorcontrib><title>COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR</title><description>The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.
La presente invención se refiere en general a compuestos antivirales, y más específicamente se dirige a combinaciones de compuestos los cuales pueden inhibir el virus de la Hepatitis C (HCV), composiciones que comprenden tales compuestos, y métodos para tratar la Hepatitis C usando tales combinaciones.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPB39vd18vRzDPH09wtW8HdTcFQIDnB19nTzdFbwcA5T8As2dVTw9PPwdPIM8Q9ScPRzAWKojLFCQJB_iKtjsCtCBQ8Da1piTnEqL5TmZpBzcw1x9tBNLciPTy0uSExOzUstifeNMDY1tDQ0cDImqAAA56ktBA</recordid><startdate>20171103</startdate><enddate>20171103</enddate><creator>STACEY A. VOSS</creator><creator>SUSAN E. CHANIEWSKI</creator><creator>MIN GAO</creator><creator>AMY K. SHEAFFER</creator><creator>FIONA MCPHEE</creator><creator>JULIE A. LEMM</creator><scope>EVB</scope></search><sort><creationdate>20171103</creationdate><title>COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR</title><author>STACEY A. VOSS ; SUSAN E. CHANIEWSKI ; MIN GAO ; AMY K. SHEAFFER ; FIONA MCPHEE ; JULIE A. LEMM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX351910B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>STACEY A. VOSS</creatorcontrib><creatorcontrib>SUSAN E. CHANIEWSKI</creatorcontrib><creatorcontrib>MIN GAO</creatorcontrib><creatorcontrib>AMY K. SHEAFFER</creatorcontrib><creatorcontrib>FIONA MCPHEE</creatorcontrib><creatorcontrib>JULIE A. LEMM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>STACEY A. VOSS</au><au>SUSAN E. CHANIEWSKI</au><au>MIN GAO</au><au>AMY K. SHEAFFER</au><au>FIONA MCPHEE</au><au>JULIE A. LEMM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR</title><date>2017-11-03</date><risdate>2017</risdate><abstract>The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.
La presente invención se refiere en general a compuestos antivirales, y más específicamente se dirige a combinaciones de compuestos los cuales pueden inhibir el virus de la Hepatitis C (HCV), composiciones que comprenden tales compuestos, y métodos para tratar la Hepatitis C usando tales combinaciones.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; spa |
| recordid | cdi_epo_espacenet_MX351910B |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T22%3A17%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=STACEY%20A.%20VOSS&rft.date=2017-11-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX351910B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |